Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahrooz Rabizadeh

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Current Alzheimer Research|January 29, 2008
APP-based neuroprotective strategiesDale E Bredesen, Shahrooz Rabizadeh
Cytokine & Growth Factor Reviews|June 6, 2003
Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR)Shahrooz Rabizadeh, Dale E Bredesen
Physiological Reviews|March 27, 2004
Apoptosis and dependence receptors: a molecular basis for cellular addictionDale E Bredesen, Patrick Mehlen, Shahrooz Rabizadeh
Annals of Neurology|April 1, 2009
Selective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interactionJoanna Fombonne, Shahrooz Rabizadeh, Surita Banwait, et al.
Biomedical Optics Express|September 20, 2013
Label-free high-throughput cell screening in flowAta Mahjoubfar, Claire Chen, Kayvan R Niazi, et al.
Neuro-Oncology Advances|February 3, 2021
Glycolytic expression in lower-grade glioma reveals an epigenetic association between IDH mutation status and PDL1/2 expressionKevin B Givechian, Chad Garner, Steve Benz, et al.
Oncotarget|July 25, 2018
CAD/POLD2 gene expression is associated with poor overall survival and chemoresistance in bladder urothelial carcinomaKevin B Givechian, Chad Garner, Hermes Garban, et al.
Bioinformatics (Oxford, England)|July 2, 2013
Learning subgroup-specific regulatory interactions and regulator independence with PARADIGMAndrew J Sedgewick, Stephen C Benz, Shahrooz Rabizadeh, et al.
Oncotarget|April 9, 2019
An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinomaKevin B Givechian, Chad Garner, Steve Benz, et al.
Oncotarget|May 4, 2018
Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancerShahrooz Rabizadeh, Chad Garner, John Zachary Sanborn, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Current Alzheimer Research|January 29, 2008
APP-based neuroprotective strategiesDale E Bredesen, Shahrooz Rabizadeh
Cytokine & Growth Factor Reviews|June 6, 2003
Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR)Shahrooz Rabizadeh, Dale E Bredesen
Physiological Reviews|March 27, 2004
Apoptosis and dependence receptors: a molecular basis for cellular addictionDale E Bredesen, Patrick Mehlen, Shahrooz Rabizadeh
Annals of Neurology|April 1, 2009
Selective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interactionJoanna Fombonne, Shahrooz Rabizadeh, Surita Banwait, et al.
Biomedical Optics Express|September 20, 2013
Label-free high-throughput cell screening in flowAta Mahjoubfar, Claire Chen, Kayvan R Niazi, et al.
Neuro-Oncology Advances|February 3, 2021
Glycolytic expression in lower-grade glioma reveals an epigenetic association between IDH mutation status and PDL1/2 expressionKevin B Givechian, Chad Garner, Steve Benz, et al.
Oncotarget|July 25, 2018
CAD/POLD2 gene expression is associated with poor overall survival and chemoresistance in bladder urothelial carcinomaKevin B Givechian, Chad Garner, Hermes Garban, et al.
Bioinformatics (Oxford, England)|July 2, 2013
Learning subgroup-specific regulatory interactions and regulator independence with PARADIGMAndrew J Sedgewick, Stephen C Benz, Shahrooz Rabizadeh, et al.
Oncotarget|April 9, 2019
An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinomaKevin B Givechian, Chad Garner, Steve Benz, et al.
Oncotarget|May 4, 2018
Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancerShahrooz Rabizadeh, Chad Garner, John Zachary Sanborn, et al.
Pageof 5